RANKL antibody

Catalog No. ABIN933803

The Mouse Monoclonal anti-RANKL antibody has been validated for WB, ELISA and Inhibition. It is suitable to detect RANKL in samples from Human.

Quick Overview for RANKL antibody (ABIN933803)

Target: RANKL (TNFSF11) (Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This RANKL antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Blocking Antibody (Inhibition)

Clone: M912290

Product Details anti-RANKL Antibody

Immunogen: RANKL antibody was raised in mouse using highly pure recombinant human sRANK ligand as the immunogen.

Isotype: IgG1 kappa

Application Details

Application Notes: Optimal conditions should be determined byt he investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized from PBS.

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.

Target Details for RANKL

Target: RANKL (TNFSF11) (Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11))

Alternative Name: RANKL

Background: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T-cell proliferation in a mixed lymphocyte reaction, to promote the survival of RANK + T cells, and to regulate T-cell-dependent immune response. RANKL, which is expressed in a variety of cells including osteoblasts, fibroblasts, activated T-cells and bone marrow stromal cells, is also capable of interacting with a decoy receptor called OPG. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. Synonyms: Monoclonal RANKL antibody, Anti-RANKL antibody, soluble Receptor Activator of NFkB Ligand antibody, TNFSF11 antibody, TRANCE antibody, TNF-related activation-induced cytokine antibody, OPGL antibody, ODF antibody, Osteoclast differentiation factor antibody.

Molecular Weight: 19.4 kDa (predicted detection band MW)

Pathways: NF-kappaB Signaling